Rispens T - Search Results

1

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.

Boekel L, Hooijberg F, Vogelzang EH, Besten YR, Leeuw M, Atiqi S, van Vollenhoven RF, Wijbrandts CA, Gerritsen M, Krieckaert C, Dijkshoorn B, Bakhlakh S, Crooijmans JJ, Voskuyl A, van der Horst-Bruinsma IE, Lems W, Kuijpers TW, van Ham SM, Wieske L, Eftimov F, Kummer LY, van Dam PK, Stalman EW, Steenhuis M, Keijzer S, Cristianawati O, Keijser J, Loeff FC, Tas SW, Nurmohamed MT, Boers M, Rispens T, Wolbink G. Boekel L, et al. Among authors: rispens t. RMD Open. 2022 Apr;8(1):e002035. doi: 10.1136/rmdopen-2021-002035. RMD Open. 2022. PMID: 35383121 Free PMC article.

2

Immunogenicity of biological therapeutics: from assay to patient.

Krieckaert C, Rispens T, Wolbink G. Krieckaert C, et al. Among authors: rispens t. Curr Opin Rheumatol. 2012 May;24(3):306-11. doi: 10.1097/BOR.0b013e3283521c4e. Curr Opin Rheumatol. 2012. PMID: 22388644 Review.

3

IgG4 production against adalimumab during long term treatment of RA patients.

van Schouwenburg PA, Krieckaert CL, Nurmohamed M, Hart M, Rispens T, Aarden L, Wouters D, Wolbink GJ. van Schouwenburg PA, et al. Among authors: rispens t. J Clin Immunol. 2012 Oct;32(5):1000-6. doi: 10.1007/s10875-012-9705-0. Epub 2012 May 24. J Clin Immunol. 2012. PMID: 22622790

4

Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation.

van Schouwenburg PA, van de Stadt LA, de Jong RN, van Buren EE, Kruithof S, de Groot E, Hart M, van Ham SM, Rispens T, Aarden L, Wolbink GJ, Wouters D. van Schouwenburg PA, et al. Among authors: rispens t. Ann Rheum Dis. 2013 Jan;72(1):104-9. doi: 10.1136/annrheumdis-2012-201445. Epub 2012 Jul 3. Ann Rheum Dis. 2013. PMID: 22759910

5

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis.

Vennegoor A, Rispens T, Strijbis EM, Seewann A, Uitdehaag BM, Balk LJ, Barkhof F, Polman CH, Wolbink G, Killestein J. Vennegoor A, et al. Among authors: rispens t. Mult Scler. 2013 Apr;19(5):593-600. doi: 10.1177/1352458512460604. Epub 2012 Sep 19. Mult Scler. 2013. PMID: 22992450

6

Monoclonal anti-citrullinated protein antibodies selected on citrullinated fibrinogen have distinct targets with different cross-reactivity patterns.

van de Stadt LA, van Schouwenburg PA, Bryde S, Kruithof S, van Schaardenburg D, Hamann D, Wolbink G, Rispens T. van de Stadt LA, et al. Among authors: rispens t. Rheumatology (Oxford). 2013 Apr;52(4):631-5. doi: 10.1093/rheumatology/kes371. Epub 2012 Dec 22. Rheumatology (Oxford). 2013. PMID: 23264551

7

Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation.

van Schouwenburg PA, Krieckaert CL, Rispens T, Aarden L, Wolbink GJ, Wouters D. van Schouwenburg PA, et al. Among authors: rispens t. Ann Rheum Dis. 2013 Oct;72(10):1680-6. doi: 10.1136/annrheumdis-2012-202407. Epub 2013 Jan 7. Ann Rheum Dis. 2013. PMID: 23300118

8

Nanomolar to sub-picomolar affinity measurements of antibody-antigen interactions and protein multimerizations: fluorescence-assisted high-performance liquid chromatography.

Rispens T, Ooijevaar-de Heer P, Derksen NI, Wolbink G, van Schouwenburg PA, Kruithof S, Aalberse RC. Rispens T, et al. Anal Biochem. 2013 Jun 15;437(2):118-22. doi: 10.1016/j.ab.2013.02.027. Epub 2013 Mar 13. Anal Biochem. 2013. PMID: 23499975

9

Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response.

Lighaam LC, Vermeulen E, Bleker Td, Meijlink KJ, Aalberse RC, Barnes E, Culver EL, van Ham SM, Rispens T. Lighaam LC, et al. Among authors: rispens t. J Allergy Clin Immunol. 2014 Jan;133(1):267-70.e1-6. doi: 10.1016/j.jaci.2013.07.044. Epub 2013 Sep 26. J Allergy Clin Immunol. 2014. PMID: 24074895 No abstract available.

10

Key findings towards optimising adalimumab treatment: the concentration-effect curve.

Pouw MF, Krieckaert CL, Nurmohamed MT, van der Kleij D, Aarden L, Rispens T, Wolbink G. Pouw MF, et al. Among authors: rispens t. Ann Rheum Dis. 2015 Mar;74(3):513-8. doi: 10.1136/annrheumdis-2013-204172. Epub 2013 Dec 10. Ann Rheum Dis. 2015. PMID: 24326008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

291 results

Search Page